JAK2 and lung carcinoma: SH2B3 interacts with Janus kinase 2 (JAK2) and Src homology region 2-containing protein tyrosine phosphatase 2 to inhibit JAK2/STAT3 and PI3K/AKT signaling pathway-mediated anoikis in lung cancer [147].